Next-generation sequencing (NGS) has fundamentally transformed precision oncology by enabling comprehensive genomic profiling of tumors, thus guiding diagnosis, prognostication, and personalized treatment selection.
Comprehensive genomic profiling (CGP) represents a paradigm shift in cancer diagnostics, moving beyond single-gene testing to simultaneously analyze hundreds of cancer-related genes and genomic signatures.
This article provides a comprehensive comparative analysis of DNA sequence representation methods, tracing their evolution from foundational computational techniques to advanced AI-driven models.
This article provides a comprehensive comparative analysis of filter and wrapper feature selection methods, tailored for researchers and professionals in drug development and biomedical sciences.
This article provides a comprehensive guide to cross-validation (CV) strategies for developing and validating machine learning models in genomic cancer classification.
The identification of cancer driver genes is fundamental to understanding oncogenesis and developing targeted therapies.
The integration of machine learning (ML) with cell-free DNA (cfDNA) analysis holds transformative potential for non-invasive cancer detection, therapy selection, and monitoring.
This article provides a comprehensive framework for researchers, scientists, and drug development professionals on managing confounding factors during the validation of cancer detection models.
This article addresses the critical challenge of data scarcity in medical genomics, a major bottleneck hindering drug discovery and precision medicine.
The analysis of circulating tumor DNA (ctDNA) has transformative potential for early cancer detection and minimal residual disease (MRD) monitoring.